eFFECTOR Therapeutics, Inc.
NASDAQ:EFTR
0.04 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -35.811 | -22.665 | 15.798 | 14.211 | -29.739 |
| Depreciation & Amortization
| 0.111 | 0.053 | 0.024 | 0.16 | 0.307 |
| Deferred Income Tax
| -0.855 | 0 | -0.539 | -0.333 | -1.987 |
| Stock Based Compensation
| 4.595 | 5.334 | 8.66 | 0.499 | 0.646 |
| Change In Working Capital
| 1.685 | 2.677 | -0.238 | -0.824 | 1.071 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.855 | 0.958 | 0.155 | -0.251 | -0.727 |
| Other Working Capital
| 0.83 | 1.719 | -0.393 | -0.573 | 1.798 |
| Other Non Cash Items
| 0.725 | -11.298 | -48.593 | 0.122 | 2.104 |
| Operating Cash Flow
| -29.55 | -25.899 | -24.888 | 13.835 | -27.598 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.097 | -0.192 | -0.042 | -0.154 | -0.004 |
| Acquisitions Net
| -14.581 | 17.668 | 0.607 | 0 | 0.088 |
| Purchases Of Investments
| -17.169 | -52.418 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 31.75 | 34.75 | 0 | 0 | 0 |
| Other Investing Activites
| 14.581 | -17.668 | 0.607 | 0 | 0.088 |
| Investing Cash Flow
| 14.484 | -17.86 | 0.565 | -0.154 | 0.084 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -13.94 | -2 | 0 |
| Common Stock Issued
| 21.233 | 2.799 | 0.056 | 0.108 | 20.329 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.086 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 6.71 | -0.034 | 72.693 | -1.892 | 20.329 |
| Financing Cash Flow
| 21.233 | 2.765 | 58.809 | -1.892 | 20.243 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 10.698 |
| Net Change In Cash
| 6.167 | -40.994 | 34.486 | 11.789 | 3.427 |
| Cash At End Of Period
| 14.875 | 8.708 | 49.702 | 15.216 | 3.427 |